Legal Information

Legal Information

Published by:

Agence France-Presse, an autonomous entity endowed with civil personality and operating in accordance with commercial rules, registered in the Paris Trade and Companies Registrar under number 775 658 354.

  • Address: 11-15, Place de la Bourse, 75002 Paris (FRANCE)
  • Phone number: 01 40 41 46 46
  • Mail: contact@afp.com

05/14/2025 01:00
NIQ: APAC Consumers Embrace Private Labels, While Name Brands Sustain Their Strength

NielsenIQ (NIQ), a leader in consumer intelligence, today released new insights from its Finding Harmony on the Shelf: 2025 Global Outlook on Private Label and Branded Products study, revealing that Asia Pacific consumers are redefining their brand preferences. Drawing from responses of over 17,000 consumers across 25 markets — including Australia, China, India, Indonesia, Singapore, South Korea, and Thailand — the report reveals how consumers in Asia Pacific are reshaping their perceptions of ...

05/23/2025 05:00
Curatis discloses Corticorelin as active substance of C-PTBE-01

An epidemiological market study commissioned by Curatis Holding AG (SIX:CURN, “Curatis”) shows that the target patient group is substantially larger than previous estimates. In the US alone, over 150,000 patients suffer from peritumoral brain edema in association with malignant tumors. In previous clinical studies, human corticorelin (C-PTBE-01), demonstrated significant benefits in the treatment of PTBE. “The prospect of developing a potential blockbuster drug with that can contribute signific...

06/12/2025 11:00
FDA Grants Priority Review for Zoliflodacin New Drug Application for the Treatment of Uncomplicated Gonorrhea and Assigns Target PDUFA Date of December 15, 2025

Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. (NASDAQ: INVA), in collaboration with the Global Antibiotic Research & Development Partnership (GARDP), today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review for the New Drug Application (NDA) for zoliflodacin, an investigational first-in-class, single dose, spiropyrimidinetrione oral antibiotic for the treatment of uncomplicated gonorrhea in adults and pediatric patients 12 years an...

06/12/2025 11:00
Supply Chain Leaders to Share Perspective on Tackling Tariffs, Trade, and Disruption During Exclusive Digital Event

As global trade tensions remain at the forefront of business decision-making, Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain orchestration, will host technology and life sciences supply chain leaders for a special tariff-focused digital event with economic futurist Andrew Busch on June 17, 2025 at 11:00am eastern. Titled, Tariffs, Trade, and Turbulence: How to Respond to Today’s Supply Chain Challenges, the event is tailored for global business leaders and will offer expert in...

06/12/2025 11:11
KAYTUS Unveils Upgraded MotusAI to Accelerate LLM Deployment

KAYTUS, a leading provider of end-to-end AI and liquid cooling solutions, today announced the release of the latest version of its MotusAI AI DevOps Platform at ISC High Performance 2025. The upgraded MotusAI platform delivers significant enhancements in large model inference performance and offers broad compatibility with multiple open-source tools covering the full lifecycle of large models. Engineered for unified and dynamic resource scheduling, it dramatically improves resource utilization ...

06/24/2025 16:11
Less Waste, More Impact: ScottsMiracle-Gro and ProAmpac Advance Insecticide Packaging

ProAmpac, a global leader in flexible packaging and material science, has partnered with ScottsMiracle-Gro to introduce a groundbreaking spouted pouch for Ortho Home Defense Max. This new packaging combines the durability of rigid containers with the efficiency of flexible packaging, offering consumers a convenient and more sustainable alternative. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250624640067/en/ProAmpac partners with...